Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 135, Issue 1, Pages 97-100Publisher
WILEY
DOI: 10.1111/j.1365-2141.2006.06245.x
Keywords
immune complex; immunoglobulin G cross-linking; thrombocytopenia
Categories
Ask authors/readers for more resources
Intravenous immunoglobulins (IVIgs) are used to treat an increasing number of autoimmune diseases, but their exact mechanism of action remains unknown. This study showed that cross-linking of human IgG present in IVIg preparations using a mouse monoclonal anti-human IgG generated complexes that prevented or reversed thrombocytopenia in mice more efficiently than IVIg. Furthermore, biologically active complexes were obtained simply by adding the monoclonal antibody to human serum. These results suggest the possible development of an IVIg-free substitute through the ex vivo, and possibly in vivo, formation of immune complexes containing autologous IgG of immune thrombocytopenic purpura patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available